Search results for "Reuptake inhibitor"

showing 10 items of 85 documents

Non-competitive inhibition of clomipramineN-demethylation by fluvoxamine

1995

The selective serotonin reuptake inhibitor fluvoxamine interferes with the metabolism of tricyclic antidepressants. The present investigation was set out to characterize these interactions in vitro using rat liver microsomes and in vivo by analysing levels of clomipramine and metabolites in sera of depressed patients treated concomitantly with fluvoxamine and clomipramine. Clomipramine was N-demethylated and hydroxylated in vitro by microsomes to N-desmethyl-clomipramine, 8-hydroxyclomipramine, and 10-hydroxyclomipramine. Kinetic analyses revealed Km values of 6.2 microM for N-demethylation and 1.2 microM for 8-hydroxylation. Fluvoxamine was a non-competitive inhibitor for N-demethylation w…

Malemedicine.medical_specialtyClomipramineSerotonin reuptake inhibitorFluvoxamineIn Vitro TechniquesPharmacologyHydroxylationRats Sprague-DawleyPharmacokineticsInternal medicinemedicineAnimalsHumansPharmacologychemistry.chemical_classificationDrug interactionRatsEndocrinologychemistryDealkylationFluvoxamineDepression ChemicalClomipramineMicrosomes LiverSerotoninReuptake inhibitormedicine.drugTricyclicPsychopharmacology
researchProduct

Effects of oxotremorine and physostigmine on the inhibitory avoidance impairment produced by amitriptyline in male and female mice.

2009

We have previously observed that amitriptyline and other antidepressants produce impairing effects on inhibitory avoidance (also called passive avoidance) in mice of both sexes. In the present study we investigated the involvement of the cholinergic system in the inhibitory avoidance impairment produced by acute amitriptyline in male and female CD1 mice. For this purpose, the effects on said task of acute i.p. administration of several doses of amitriptyline, either alone or in combination with the cholinergic agonists oxotremorine and physostigmine, were evaluated. Pre-training administration of 5, 7.5, 10 or 15 mg/kg of amitriptyline produced a significant impairment of inhibitory avoidan…

Malemedicine.medical_specialtyPhysostigmineTime FactorsAmitriptylinePhysostigmineMice Inbred StrainsPharmacologyAntidepressive Agents TricyclicCholinergic AgonistsBehavioral Neurosciencechemistry.chemical_compoundMiceRandom AllocationInternal medicineOxotremorineAvoidance LearningMedicineAnimalsAmitriptylineNeurotransmitterCholinesteraseSex Characteristicsbiologybusiness.industryLearning DisabilitiesOxotremorineEndocrinologychemistrybiology.proteinAntidepressantCholinergicFemalebusinessReuptake inhibitormedicine.drugBehavioural brain research
researchProduct

Effects of co-administration of amitriptyline and fluoxetine on inhibitory avoidance in mice

2010

We have previously observed that, while the impairing effects of amitriptyline on inhibitory avoidance in mice are consistently observed, those of acute fluoxetine are negligible. Two experiments were designed to investigate whether a regular dose of fluoxetine potentiates the effect of a low dose of amitriptyline that is ineffective when administered alone. Male and female CD1 mice were administered i.p. 30 min before training, as follows. In the first experiment, they were injected with saline, one of three doses of amitriptyline (2.5, 5, 10 mg/kg), one dose of fluoxetine (15 mg/kg), or a combination of amitriptyline (2.5 mg/kg) and fluoxetine (15 mg/kg). In the second experiment, the mic…

Malemedicine.medical_specialtyRatónAmitriptylinemedicine.medical_treatmentMice Inbred StrainsPharmacologyMiceBehavioral Neurosciencechemistry.chemical_compoundSex FactorsFluoxetineInternal medicineAvoidance LearningmedicineAnimalsAmitriptylineNeurotransmitterSalineFluoxetineDose-Response Relationship Drugbusiness.industryDrug SynergismAntidepressive AgentsEndocrinologychemistryCatecholamineFemaleSerotoninReuptake inhibitorbusinessmedicine.drugBehavioural Brain Research
researchProduct

Association Between Citalopram Serum Levels and Clinical Improvement of Patients With Major Depression

2011

Imaging studies have shown that serum concentrations of the selective serotonin reuptake inhibitor citalopram correlate with serotonin transporter (5-HTT) occupancy in vivo. In patients with major depressive disorders treated with citalopram, 80% 5-HTT occupancy was considered to be necessary for maximal therapeutic effects, which requires citalopram serum concentrations of at least 50 ng/mL. The aim of this study was to compare treatment outcome in patients with citalopram serum concentrations greater than and less than 50 ng/mL after 7 days of treatment. This study included inpatients with acute major depressive disorder according to International Classification of Disease, 10th Revision …

Malemedicine.medical_specialtySerotonin reuptake inhibitorCitalopramCitalopramSeverity of Illness Indexbehavioral disciplines and activitiesGastroenterologyInternal medicinemental disordersSeverity of illnessmedicineHumansPharmacology (medical)Adverse effectDepressive Disorder Majormedicine.diagnostic_testTherapeutic effectLength of StayMiddle Agedmedicine.diseasePsychiatry and Mental healthTherapeutic drug monitoringAnesthesiaMajor depressive disorderFemaleDrug MonitoringReuptake inhibitorPsychologySelective Serotonin Reuptake Inhibitorsmedicine.drugJournal of Clinical Psychopharmacology
researchProduct

Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment.

2006

Analysis of post-mortem tissue from patients with affective disorders has revealed a decreased number of glial cells in several brain areas. Here, we examined whether long-term psychosocial stress influences the number and morphology of hippocampal astrocytes in an animal model with high validity for research on the pathophysiology of major depression. Adult male tree shrews were submitted to 5 weeks of psychosocial stress, after which immunocytochemical and quantitative stereological techniques were used to estimate the total number and somal volume of glial fibrillary acidic protein-positive astrocytes in the hippocampal formation. Stress significantly decreased both the number (-25%) and…

Malemedicine.medical_specialtySerotonin reuptake inhibitorHippocampusHippocampal formationHippocampus03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineFluoxetinemedicineAnimalsNeurotransmitter030304 developmental biologyPharmacologyTupaia0303 health sciencesFluoxetineNeuronal PlasticityPsychiatry and Mental healthEndocrinologymedicine.anatomical_structurechemistryAstrocytesChronic DiseaseAntidepressantNeurogliaPsychologyNeuroscienceNeuroglia030217 neurology & neurosurgeryStress PsychologicalAstrocytemedicine.drugNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
researchProduct

Serum concentrations of hydroxybupropion for dose optimization of depressed patients treated with bupropion.

2014

Background Bupropion is a dopamine and norepinephrine reuptake inhibitor approved for the treatment of depression and smoking cessation. According to the recently published reviews, it is a candidate for therapeutic drug monitoring (TDM) to improve therapeutic outcomes and reduce risks of intolerability or intoxication. In practice, however, the use of TDM is limited due to the chemical instability of bupropion. This investigation sought to determine if the major, active, and chemically stable metabolite 4-hydroxybupropion is a suitable measure to guide antidepressant drug therapy with bupropion. Methods 4-Hydroxybupropion serum levels were measured using a newly developed and validated hig…

Malemedicine.medical_specialtyUrologyNorepinephrine reuptake inhibitorPharmacokineticsmedicineHumansPharmacology (medical)BupropionChromatography High Pressure LiquidRetrospective StudiesPharmacologyBupropionDepressive Disordermedicine.diagnostic_testbusiness.industryTherapeutic effectHydroxybupropionMiddle AgedTherapeutic drug monitoringArea Under CurveClinical Global ImpressionAntidepressantAntidepressive Agents Second-GenerationFemalebusinessmedicine.drugHalf-LifeTherapeutic drug monitoring
researchProduct

Effect of sertraline treatment on benzodiazepine receptors in the rat brain.

1993

In this paper we describe the modification of benzodiazepine (BDZ) binding sites in the rat brain after different times of treatment with the 5-hydroxytryptamine-(5HT) uptake blocker sertraline. We investigated the effect of 8, 15 and 30 days sertraline treatment (10 mg/kg/day, i.p.) on 3 H-flunitrazepam binding sites. In order to describe the anatomical site of action of the drug, the experiment has been carried out by means of quantitative receptor autoradiography. After 8 days of sertraline treatment, an increase of BDZ receptor density is found in the olfactory tubercle. This effect is reversed at 15 and 30 days. At 15 days of treatment, an increase is found in the anterior cingulate co…

Malemedicine.medical_specialtymedicine.drug_classRats Sprague-DawleyInternal medicineSertralinemedicineLimbic SystemAnimalsReceptorBiological Psychiatry5-HT receptorBrain ChemistryCerebral CortexBenzodiazepineSertralineBehavior AnimalGABAA receptorChemistryOlfactory tubercleBody WeightSeptal nucleiOlfactory PathwaysReceptors GABA-AAntidepressive AgentsRatsPsychiatry and Mental healthmedicine.anatomical_structureEndocrinology1-NaphthylamineNeurologyAnti-Anxiety AgentsCerebral cortexNeurology (clinical)Selective Serotonin Reuptake Inhibitorsmedicine.drugJournal of neural transmission. General section
researchProduct

Intracerebral Hemorrhage and Outcome After Thrombolysis in Stroke Patients Using Selective Serotonin-Reuptake Inhibitors.

2017

Background and Purpose— Selective serotonin-reuptake inhibitors (SSRIs) impair platelet function and have been linked to a higher risk of spontaneous intracerebral hemorrhage—an association that may be augmented by oral anticoagulants (OAC). We aimed to assess whether preadmission treatment with SSRIs in patients with acute ischemic stroke is associated with post-thrombolysis symptomatic intracerebral hemorrhage (sICH) and functional outcome. Methods— A multicenter retrospective analysis was conducted in prospective registries of patients treated by thrombolysis within 4.5 hours of stroke onset. The association between preadmission treatment with SSRIs and sICH (ECASS II definition [Europe…

Malemedicine.medical_specialtytherapeutic use [Anticoagulants]medicine.medical_treatmentSubgroup analysisepidemiology [Cerebral Hemorrhage]Risk AssessmentCohort Studies03 medical and health sciencesadverse effects [Serotonin Uptake Inhibitors]0302 clinical medicineModified Rankin ScaleInternal medicinemedicineHumansThrombolytic Therapy030212 general & internal medicineddc:610610 Medicine & healthStrokeCerebral HemorrhageAgedRetrospective StudiesAdvanced and Specialized NursingIntracerebral hemorrhageAged 80 and overtherapy [Cerebral Hemorrhage]business.industryAnticoagulantsThrombolysisOdds ratioMiddle Agedmedicine.diseaseadverse effects [Selective Serotonin Reuptake Inhibitors]Prognosisdrug therapy [Stroke]StrokeTreatment OutcomeAnesthesiaConcomitantSerotonin Uptake InhibitorsFemaleNeurology (clinical)Cardiology and Cardiovascular Medicinebusiness030217 neurology & neurosurgerySelective Serotonin Reuptake Inhibitorsepidemiology [Stroke]Cohort study
researchProduct

Animal Models of Stress - Current Knowledge and Potential Directions

2021

Finding new therapies and new antidepressant agents is of high clinical priority given that many cases of depressive disorder do not respond to conventional monoaminergic antidepressants such as selective serotonin reuptake inhibitors, tricyclic antidepressants, and monoamine oxidase inhibitors The authors demonstrated that electroacupuncture and fluoxetine, a second-generation antidepressant categorized as a selective serotonin reuptake inhibitor (Perez-Caballero et al , 2014), regulate the expression of key proteins in the calmodulin kinase (CAMK) signaling pathway, which are related to depression in the hippocampi of rats (Takemoto-Kimura et al , 2017;Xie et al , 2019) In a paper on “Sho…

Monoamine oxidaseCognitive NeuroscienceSerotonin reuptake inhibitorContext (language use)Pharmacologyalternative therapylcsh:RC321-571stress03 medical and health sciencesBehavioral Neurosciencechemistry.chemical_compound0302 clinical medicineorganoselenium compoundsMonoaminergicmedicineNeurotransmitterlcsh:Neurosciences. Biological psychiatry. Neuropsychiatry030304 developmental biologychemistry.chemical_classification0303 health sciencesFluoxetinebusiness.industryanimal modelsEditorialNeuropsychology and Physiological PsychologychemistryAntidepressantmajor depressionbusiness030217 neurology & neurosurgeryTricyclicmedicine.drugFrontiers in Behavioral Neuroscience
researchProduct

Dietary l-tryptophan leaves a lasting impression on the brain and the stress response

2017

AbstractComparative models suggest that effects of dietary tryptophan (Trp) on brain serotonin (5-hydroxytryptamine; 5-HT) neurochemistry and stress responsiveness are present throughout the vertebrate lineage. Moreover, hypothalamic 5-HT seems to play a central role in control of the neuroendocrine stress axis in all vertebrates. Still, recent fish studies suggest long-term effects of dietary Trp on stress responsiveness, which are independent of hypothalamic 5-HT. Here, we investigated if dietary Trp treatment may result in long-lasting effects on stress responsiveness, including changes in plasma cortisol levels and 5-HT neurochemistry in the telencephalon and hypothalamus of Atlantic sa…

Monoamines0301 basic medicinemedicine.medical_specialtyHydrocortisoneSalmo salarMedicine (miscellaneous)5-HIAA 5-hydroxyindoleacetic acid03 medical and health sciences0302 clinical medicineStress Physiologicalbiology.animalInternal medicinemedicineAnimalsNeurochemistryHPI hypothalamic–pituitary–interrenalBrain ChemistryNutrition and DieteticsSSRI supplementation and serotonin reuptake inhibitorsbiology5-Hydroxyindoleacetic acidCerebrumTrp tryptophanTryptophanTryptophanBrainVertebratel-TryptophanAnimal Feed030104 developmental biologyMonoamine neurotransmitterEndocrinologymedicine.anatomical_structure5-HT 5-hydroxytryptamine (serotonin)HypothalamusDietary SupplementsLong-term effectsSerotonin030217 neurology & neurosurgerymedicine.drug
researchProduct